Beyond Spontaneous Reporting: integrating data from multiple sources to ensure medicines safety
The Drug Safety Research Unit (DSRU) hosts an important international meeting for the International Society of Pharmacovigilance (ISoP). The meeting will explore many future horizons for pharmacovigilance.
We are delighted to host this year’s Mid-Year Symposium of the International Society of Pharmacovigilance (ISoP), entitled Beyond Spontaneous Reporting: integrating data from multiple sources to ensure medicines safety.
The symposium brings together many high calibre speakers from all over the world, who will present their work in sessions on observational studies, pharmacogenomics, real world data, causality, clinical trials and much more.
The programme includes several presentations from our research team. Our Chief Medical Officer, Dr Miranda Davies, will present a case study for Formal Benefit-Risk Evaluation. DSRU Research Fellow, Dr Ali Yeomans, will explain how she has used pharmacovigilance and clinical pharmacology to unravel myocarditis after Covid vaccination. DSRU Director, Prof Saad Shakir, will describe the contribution of observational studies to our understanding of drug safety issues.
The symposium promises to be a valuable opportunity for learning and networking for the international pharmacovigilance community.